To investigate the therapeutic potential of As2O3 on ALT inhibition, we examined the ability of As2O3 to target PML bodies and APB formation in tumor xenografts generated by subcutaneously injecting SaOS2 ALT cancer cells into nude mice. This evidence concerns the gene RNPEP and neoplasm.